Drug Como Tolerated In Lung And Breast Cancer Patients Shows Positive Response For Hodgkin’s Disease In Young Adults

News — By on March 23, 2009 at 5:00 am

New research published in the latest print edition of the Journal of Clinical Oncology (Vol. 27, No. 9) shows a treatment combination used in breast and lung cancers to be effective against Hodgkin’s disease in pre-teens and young adults. Richard Drachtman, MD, the interim chief and medical director of the Division of Pediatric Hematology/Oncology at The Cancer Institute of New Jersey (CINJ) is a member of the author team.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback